Results 51 to 60 of about 86,335 (163)

Peripheral Classic and Intermediate Monocyte Subsets as Immune Biomarkers of Systemic Lupus Erythematosus Disease Activity

open access: yesActa Medica Indonesiana
Background: Monocytes are evolutionarily preserved innate immune cells that play essential roles in immune response regulation. Three activated monocyte subsets—classical (CD14++CD16–), intermediate (CD14++CD16+), and nonclassical (CD14+CD16++)—are ...
Amaylia Oehadian   +8 more
doaj  

Acute confusional state in SLE. Coexisting SLE and non-SLE etiology

open access: yesSBR 2021 Congresso Brasileiro de Reumatologia, 2021
Daniela Gomes Chicre Oliveira   +10 more
openaire   +1 more source

Oral Lesion Management in Juvenile SLE with Hepatosplenomegaly

open access: yesInternational Medical Case Reports Journal
Adrianus Surya Wira Rajasa,1 Wahyu Hidayat2 1Oral Medicine Residency Program, Faculty of Dentistry, Padjadjaran University, Bandung, Indonesia; 2Department of Oral Medicine, Faculty of Dentistry, Padjadjaran University, Bandung, IndonesiaCorrespondence ...
Rajasa ASW, Hidayat W
doaj  

Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections

open access: yesPatient Preference and Adherence, 2019
Johanna Mucke, Ralph Brinks, Rebecca Fischer-Betz, Jutta G Richter, Oliver Sander, Matthias Schneider, Gamal Chehab Policlinic and Hiller Research Unit for Rheumatology, Heinrich Heine University Duesseldorf, Duesseldorf, GermanyCorrespondence: Johanna ...
Mucke J   +6 more
doaj  

Usefulness in daily practice of the Systemic Lupus Erythematosus Disease Activity Index 2000 scale and the Systemic Lupus Erythematosus Disease Activity Score index for assessing the activity of systemic lupus erythematosus

open access: yesRheumatology
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by high hetero­geneity of clinical manifestations and an uncertain prognosis. Although the mortality rate due to SLE has decreased significantly in recent decades, there is still a
Dorota Suszek   +9 more
doaj   +1 more source

Dermatological Manifestation of SLE Patients, Living in Aseer Region

open access: yesJournal of Family Medicine and Primary Care
Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease that affects both men and women differently and has a variety of multisystemic symptoms. One of the diseases most often affected target organs is the skin.
Nouf A. Alhammadi   +8 more
doaj   +1 more source

Anifrolumab in the treatment of recurrent systemic lupus erythematosus: the first post-trial case report

open access: yesCentral European Journal of Immunology
Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease whose treatment is still a challenge. The latest registration of anifrolumab for the treatment of moderate-to-severe SLE raises hopes because of its novel anti-interferon ...
Przemysław Borowy   +5 more
doaj   +1 more source

AhR in SLE [PDF]

open access: yesNature Reviews Nephrology, 2018
openaire   +2 more sources

Prediction of Flares in Systemic Lupus Erythematosus During Post-Remission Follow-up

open access: yesJournal of Inflammation Research
Yu Bai,1 Jiuliang Zhao,1 Qian Wang,1 Dong Xu,1 Xiaofeng Zeng,1 Xinping Tian,1 He-Jun Li,2 Mengtao Li1 1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical ...
Bai Y   +7 more
doaj  

Slender lobes is a spindle matrix protein regulated by spindle envelope kinase Greatwall in oocytes. [PDF]

open access: yesJ Cell Biol
Kaade R   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy